RecruitingNCT06798740

Post Market Registry Study of Intracranial Aneurysms Treated With Sugita Clipping Devices

Sponsor

Mizuho Corporation

Enrollment

150 participants

Start Date

Apr 14, 2025

Study Type

OBSERVATIONAL

Conditions

Brain aneurysm

Summary

The objective of this study is to verify the performance and safety of the Sugita Aneurysm Clips devices when used as intended and to identify possible risk factors. Data collected will be used to support the continuing performance and safety of the devices in the post-market use environment in Europe. Subjects who have an intracranial aneurysm that the physician intends to treat with the subject devices will be included in the study. Subjects will be followup as per hospital standard of care for 5 years.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Sugita Titanium Aneurysm Clip II for people with brain aneurysm. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESugita Titanium Aneurysm Clip II

Aneurysm clipping is a surgical procedure used to treat brain aneurysms.

Locations(1)

Universitätsklinikum Essen

Essen, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06798740

Related Trials

The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

NCT0714301921 locations

Multimodal Biocollection Linked to the French Register of Intracranial Aneurysms

NCT0668941026 locations